|Articles|December 15, 2002

Three other glaucoma trials addressing IOP and visual field damage:

This study was designed to determine treatment sequences in patients whose advanced glaucoma was not able to be adequately controlled with maximum medical therapy.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME